Kumho HT, Inc.

Equities

A214330

KR7214330003

Auto, Truck & Motorcycle Parts

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
601 ^KRW	-0.83%		+1.69%	-6.09%

Apr. 18	Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 19.0999977 billion in funding from Osung Advanced Materials Co., Ltd., Kumho HT, Inc., CrystalGenomics Invites Co., LTD.	CI
Jan. 25	Hwail Pharmaceutical Co.,Ltd. announced extension to the offering period	CI

Kumho HT, Inc announced that it has received KRW 8.7 billion in funding from BH Co., Ltd.

November 02, 2022

On November 3, 2022, Kumho HT, Inc closed the transaction. The company announced a private placement of series 12 unregistered coupon unguaranteed private convertible bond for the gross proceeds of KRW 8,700,000,000 on November 3, 2022. The transaction will include participation from BH Co., Ltd. The bonds carry 2% maturity rate, 2% coupon rate and will mature on November 9, 2025.

The bonds are 100% convertible into 8,546,168 shares at an conversion price of KRW 1,018. The bonds are convertible from November 9, 2023 and ends on October 9, 2025. The transaction was approved by the board of directors of the company.

The transaction is expected to close on November 9, 2022.

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	BH CO., LTD.	20,700 KRW	+17.35%	+24.03%	484M
	KUMHO HT, INC.	601 KRW	-0.83%	+1.69%	90.39M

Latest news about Kumho HT, Inc.

Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 19.0999977 billion in funding from Osung Advanced Materials Co., Ltd., Kumho HT, Inc., CrystalGenomics Invites Co., LTD.	Apr. 17	CI
Hwail Pharmaceutical Co.,Ltd. announced extension to the offering period	Jan. 24	CI
Kumho HT, Inc announced that it has received KRW 4.99999955 billion in funding from Eco Volt Co.,Ltd.	Jan. 21	CI
An unknown buyer cancelled the acquisition of 2.40% stake in CrystalGenomics, Inc. from Kumho HT, Inc.	Dec. 13	CI
Hwail Pharmaceutical Co.,Ltd. announced that it expects to receive KRW 25.999996662 billion in funding from Osung Advanced Materials Co., Ltd., Kumho HT, Inc., CrystalGenomics Invites Co., LTD.	23-10-11	CI
Kumho HT, Inc Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
An unknown buyer agreed to acquire approximately 2.40% stake in CrystalGenomics, Inc. from Kumho HT, Inc for KRW 28 billion.	23-03-29	CI
Kumho HT, Inc's Equity Buyback announced on September 28, 2022 has expired with 6,260,000 shares, representing 3.29% for KRW 6,814.16 million.	23-03-26	CI
Tranche Update on Kumho HT, Inc's Equity Buyback Plan announced on September 28, 2022.	23-03-26	CI
Tranche Update on Kumho HT, Inc's Equity Buyback Plan announced on September 28, 2022.	23-03-26	CI
Tranche Update on Kumho HT, Inc's Equity Buyback Plan announced on September 28, 2022.	23-03-26	CI
Kumho HT, Inc announced that it has received KRW 8.7 billion in funding from BH Co., Ltd.	22-11-02	CI
Kumho HT, Inc announced that it expects to receive KRW 10 billion in funding from BH Co., Ltd.	22-10-24	CI
Kumho HT, Inc announces an Equity Buyback for KRW 7,000 million worth of its shares.	22-09-27	CI
Kumho HT, Inc authorizes a Buyback Plan.	22-09-27	CI
CrystalGenomics, Inc. announced that it has received KRW 5.7075 billion in funding from Kumho HT, Inc	22-08-07	CI
CrystalGenomics, Inc. announced that it expects to receive KRW 5.7075 billion in funding from Kumho HT, Inc	22-07-28	CI
Kumho HT, Inc announced a financing transaction	22-05-06	CI
An unknown buyer agreed to acquire approximately 16.5% stake in DiNonA Inc. from Kumho HT, Inc for KRW 19.9 billion.	21-11-02	CI
Kumho HT, Inc. completed the acquisition of remaining 81% stake in DiNonA Inc..	21-10-26	CI
Kumho HT, Inc(KOSE:A214330) added to S&P Global BMI Index	21-09-20	CI
CrystalGenomics, Inc. announced that it has received KRW 15.24 billion in funding from Kumho HT, Inc.	20-09-17	CI
Kumho HT, Inc. agreed to acquire remaining 81% stake in DiNonA Inc. for approximately KRW 170 billion.	20-08-26	CI
An unknown buyer agreed to acquire a 8.5% stake in Kumho HT, Inc. for KRW 17.2 billion.	20-08-17	CI
Kumho HT, Inc. acquired 3.11% stake in CrystalGenomics, Inc. from Jung-myeong Cho for KRW 28 billion.	20-07-30	CI

Chart Kumho HT, Inc.

Duration

Period

More charts

Company Profile

KUMHO HT, INC is a Korea-based company mainly engaged in the manufacture of automotive lighting components. The Company operates its business through two segments: light emitting diode (LED) modules segment, which manufactures fog lamps, side marker lamps, turn signals, side repeaters, daytime running lights (DRLs), rear combination lamps (RCLs), stop lamps, back-up lamps, center high mounted stop lamps (CHMSLs) and others, and incandescent lamps segment, which manufactures wedge bulbs, festoon bulbs and others. The Company distributes its products within domestic market and to overseas markets.

Sector

Auto, Truck & Motorcycle Parts

Calendar

2024-05-08 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Automotive Accessories

	1st Jan change	Capi.
KUMHO HT, INC.	-6.09%	90.39M
GENTEX CORPORATION	+4.50%	7.89B
CHANGZHOU XINGYU AUTOMOTIVE LIGHTING SYSTEMS CO.,LTD.	+1.71%	5.26B
THULE GROUP AB	+11.99%	3.01B
TOYOTA BOSHOKU CORPORATION	+2.97%	2.69B
ADIENT PLC	-24.61%	2.5B
NINGBO JIFENG AUTO PARTS CO., LTD.	-1.48%	2.31B
PHINIA INC.	+35.62%	1.88B
KUNSHAN HUGUANG AUTO HARNESS CO.,LTD.	+45.03%	1.74B
NINGBO HUAXIANG ELECTRONIC CO., LTD.	+6.99%	1.54B

Automotive Accessories